Francis Odonnell - Dec 13, 2022 Form 3 Insider Report for Inhibitor Therapeutics, Inc. (INTI)

Role
Chief Executive Officer, Executive Chairman of the Board, Director, 10%+ Owner
Signature
/s/ Francis O'Donnell
Stock symbol
INTI
Transactions as of
Dec 13, 2022
Transactions value $
$0
Form type
3
Date filed
12/22/2022, 08:33 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding INTI Common Stock 85.6M Dec 13, 2022 See Footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent 6,000,000 shares of common stock held by Hopkins Capital Group II, LLC ("HCG II LLC") and 79,627,069 shares of common stock held by Hedgepath, LLC ("HP LLC").
F2 Francis E. O'Donnell Irrevocable Trust #1 owns 28.12% of HCG II LLC and Francis E. O'Donnell Descendants Trust owns 3.13% of HCG II LLC. Kathleen M . O'Donnell, Dr. O'Donnell's sister, is the trustee of Francis E. O'Donnell Irrevocable Trust #1 and Francis E. O'Donnell Descendants Trust. Dr. O'Donnell does not have voting and dispositive control over any of these shares and disclaims any beneficial ownership of the reported shares held by HCG II LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
F3 The Francis E. O'Donnell Jr. Irrevocable Trust #7 owns 26.5% of HP LLC. Kathleen M. O'Donnell, Dr. O'Donnell's sister, is the trustee of HP LLC. Dr. O'Donnell does not have voting and dispositive control over any of these shares and disclaims any beneficial ownership of the reported shares held by HP LLC other than to the extent of any pecuniary interest he may have therein, directly or indirectly.

Remarks:

Chief Executive Officer, Executive Chairman of the Board